Cargando…
Tranexamic Acid Inhibits Angiogenesis and Melanogenesis in Vitro by Targeting VEGF Receptors
Melasma is a common but complex skin condition concerning cosmetic problems. Tranexamic acid (TA) has been proved to be effective in treatment of melasma with still unclear mechanisms. Here, we show that VEGF165 enhanced the expression of VEGF receptors (VEGFRs, including VEGFR-1, VEGFR-2 and NRP-1)...
Autores principales: | Zhu, Jian-Wei, Ni, Ya-Jie, Tong, Xiao-Yun, Guo, Xia, Wu, Xiao-Ping, Lu, Zhong-Fa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163366/ https://www.ncbi.nlm.nih.gov/pubmed/32308543 http://dx.doi.org/10.7150/ijms.44188 |
Ejemplares similares
-
Tranexamic Acid Diminishes Laser-Induced Melanogenesis
por: Kim, Myoung Shin, et al.
Publicado: (2015) -
Pimecrolimus increases the melanogenesis and migration of melanocytes in vitro
por: Xu, Ping, et al.
Publicado: (2017) -
Glycation of fibronectin inhibits VEGF‐induced angiogenesis by uncoupling VEGF receptor‐2‐c‐Src crosstalk
por: Chen, Tangting, et al.
Publicado: (2020) -
A novel peptide specifically binding to VEGF receptor suppresses angiogenesis in vitro and in vivo
por: Zhang, Yuan, et al.
Publicado: (2017) -
Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2–αvβ3 integrin cross-talk
por: Wang, L, et al.
Publicado: (2015)